Drugmaker to testify on why weight-loss drugs cost 15x more in the US
After some persuasion from Sen. Bernie Sanders (I-Vt.), the CEO of Novo Nordisk will testify before lawmakers later this year on the "outrageously high cost" of the company's diabetes and weight-loss drugs—Ozempic and Wegovy—in the US.
CEO Lars Jørge... [2915 chars]
Source: Ars Technica
